The Sympathorenal Axis in Hypertension and Heart Failure

Journal of Cardiac Failure

Volumn 16, Issue 5, 2010, Pages 369-373

  Goldsmith, Steven R ^a   Sobotka, Paul A ^a   Bart, Bradley A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MOXONIDINE; VASODILATOR AGENT;

ADRENERGIC SYSTEM; ARTICLE; CAROTID SINUS NERVE; CLINICAL TRIAL; DOSE RESPONSE; HEART FAILURE; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY FUNCTION; KIDNEY INNERVATION; KIDNEY TUBULE ABSORPTION; NERVE STIMULATION; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RISK FACTOR;

AFFERENT PATHWAYS; ANTIHYPERTENSIVE AGENTS; HEART FAILURE; HUMANS; HYPERTENSION; KIDNEY; REGIONAL BLOOD FLOW; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; TREATMENT FAILURE; VASOMOTOR SYSTEM; WATER-ELECTROLYTE BALANCE;

EID: 77951640756     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.12.022     Document Type: Article

References (38)

1. Francis G.S., Goldsmith S.R., Levine T.B., et al. The neurohumoral axis in congestive heart failure. Ann Intern Med 101 (1984) 370-377
2. DiBona G.F., and Kopp U.C. Neural control of renal function. Physiol Rev 77 (1997) 75-97
3. DiBona G.F. Neural control of the kidney: past, present, and future. Hypertension 41 (2003) 621-624
4. Bell-Reuss E., Trevino D.L., and Gottschalk C.W. Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest 57 (1976) 1104-1107
5. Zanchetti A.S. Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension. Circulation 56 (1977) 691-698
6. Kirchheim H., Ehmke H., and Persson P. Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin Wochenschr 67 (1989) 858-864
7. Shlipak M.G., and Massie B.M. The clinical challenge of cardiorenal syndrome. Circulation 110 (2004) 1514-1517
8. Katholi R.E., Hageman G.R., Whitlow P.L., et al. Hemodynamic and afferent renal nerve responses to intrarenal adenosine in the dog. Hypertension 5 (1983) I149-I154
9. Campese V.M., and Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25 (1995) 878-882
10. Converse Jr. R.L., Jacobsen T.N., Toto R.D., et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327 (1992) 1912-1918
11. Hausberg M., Kosch M., Harmelink P., et al. Sympathetic nerve activity in end-stage renal disease. Circulation 106 (2002) 1974-1979
12. Schlaich M., Krum H., Walton T., Lambert G., Sobotka P., and Esler M. A novel catheter based approach to denervate the human kidney reduces blood pressure and muscle sympathetic nerve activity in a patient with end stage renal disease and hypertension. J Hypertension 27 Suppl 4 (2009) s437
13. Zucker I.H. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48 (2006) 1005-1011
14. Triposkiadis F., Karayannis G., Giamouzis G., et al. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54 (2009) 1747-1762
15. DiBona G.F. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 11 (2002) 197-200
16. Katholi R.E. Renal nerves and hypertension: an update. Fed Proc 44 (1985) 2846-2850
17. Katholi R.E. Renal nerves in the pathogenesis of hypertension in experimental animals and humans. Am J Physiol 245 (1983) F1-14
18. Gordon R.D., Bachmann A.W., Jackson R.V., et al. Increased sympathetic activity in renovascular hypertension in man. Clin Exp Pharmacol Physiol 9 (1982) 277-281
19. Morrissey D.M., Brookes V.S., and Cooke W.T. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet 1 (1953) 403-408
20. Smithwick R.H., and Thompson J.E. Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc 152 (1953) 1501-1504
21. Schlaich M.P., Sobotka P.A., Krum H., et al. Renal sympathetic nerve ablation for the treatment of uncontrolled hypertension. N Engl J Med 36 (2009) 932-934
22. Hasking G.J., Esler M.D., Jennings G.L., et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73 (1986) 615-621
23. Leimbach Jr. W.N., Wallin B.G., Victor R.G., et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73 (1986) 913-919
24. Levine T.B., Francis G.S., Goldsmith S.R., et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49 (1982) 1659-1666
25. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in pati.e., nts with chronic congestive heart failure. N Engl J Med 311 (1984) 819-823
26. Aggarwal A., Esler M.D., Morris M.J., et al. Regional sympathetic effects of low-dose clonidine in heart failure. Hypertension 41 (2003) 553-557
27. Olivari M.T., Levine T.B., and Cohn J.N. Acute hemodynamic and hormonal effects of central vs. peripheral sympathetic inhibition in patients with congestive heart failure. J Cardiovasc Pharm 8 (1986) 973-977
28. Coats A.J. Heart Failure 99-the MOXCON story. Int J Cardiol 71 (1999) 109-111
29. Petersson M., Friberg P., Eisenhofer G., et al. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J 26 (2005) 906-913
30. Nozawa T., Igawa A., Fujii N., et al. Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessels 16 (2002) 51-56
31. Francis G.S., Siegel R.M., Goldsmith S.R., et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 103 (1985) 1-6
32. Thames M.D. Acetylstrophanthidin-induced reflex inhibition of canine renal sympathetic nerve activity mediated by cardiac receptors with vagal afferents. Circ Res 44 (1979) 8-15
33. Ferguson D.W., Berg W.J., Sanders J.S., et al. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation 80 (1989) 65-77
34. Gheorghiade M., and Pang P.S. Acute heart failure syndromes. J Am Coll Cardiol 53 (2009) 557-573
35. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 200;373:1275-1281.
36. Illig K.A., Levy M., Sanchez L., et al. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg 44 (2006) 1213-1218
37. Lohmeier T.E., Hildebrandt D.A., Warren S., et al. Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integr Comp Physiol 288 (2005) R828-R836
38. Zucker I.H., Hackley J.F., Cornish K.G., et al. Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension 50 (2007) 904-910